Evidence map›Paper›PMID 35634719›Full record

ArticlemAbs

The proximity of the N- and C- termini of bovine knob domains enable engineering of target specificity into polypeptide chains.

Alice Hawkins, Callum Joyce, Kevin Brady, Adam Hold, Alan Smith, Michael Knight, Conor Howard, Jean van den Elsen, Alastair D G Lawson, Alex Macpherson

Open access · goldAbstract read
In one paragraph

Article in mAbs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Alice HawkinsEarly Solutions UCB Biopharma UK, Slough, UK.
Callum JoyceEarly Solutions UCB Biopharma UK, Slough, UK.
Kevin BradyEarly Solutions UCB Biopharma UK, Slough, UK.
Adam HoldEarly Solutions UCB Biopharma UK, Slough, UK.
Alan SmithBiotech Solutions, UCB Biopharma UK, Slough, UK.
Michael KnightBiotech Solutions, UCB Biopharma UK, Slough, UK.
Conor HowardEarly Solutions UCB Biopharma UK, Slough, UK.
Jean van den ElsenDepartment of Biology and Biochemistry, University of Bath, Bath, UK.
Alastair D G LawsonEarly Solutions UCB Biopharma UK, Slough, UK.
Alex MacphersonEarly Solutions UCB Biopharma UK, Slough, UK.ORCID 0000-0002-4508-5322
Biopharma Technology (United Kingdom) · GBUniversity of Bath · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cysteine-rich knob domains can be isolated from the ultralong heavy-chain complementarity-determining region (CDR) 3, which are unique to a subset of bovine antibodies, to create antibody fragments of ~4 kDa. Advantageously, the N- and C- termini of these small binding domains are in close proximity, and we propose that this may offer a practical route to engineer extrinsic binding specificity into proteins. To test this, we transplanted knob domains into various loops of rat serum albumin, targeting sites that were distal to the interface with the neonatal Fc receptor. Using knob domains raised against the clinically validated drug target complement component C5, we produced potent inhibitors, which exhibit an extended plasma half-life

Indexed as

Antibodies, BispecificComplementarity Determining RegionsAnimalsCattleComplement ActivationProtein DomainsRatsAntibodies, BispecificComplementarity Determining RegionsbispecificBovine antibodiescomplement C5knob domainserum albuminVHH

Identifiers

PMID35634719
PMCPMC9154775
OpenAlexW4282036521

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.